Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life

BACKGROUND: To overcome nonadherence in patients with psychosis switch to long-acting injectable (LAI) antipsychotic formulations is adopted. Most oral versus LAI comparisons showed similar antipsychotic responses. Psychoses often overlap with substance use disorder (SUD). Head-to-head LAI compariso...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuomo, Ilaria, Kotzalidis, Georgios D, de Persis, Simone, Piacentino, Daria, Perrini, Filippo, Amici, Emanuela, De Filippis, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016599/
https://www.ncbi.nlm.nih.gov/pubmed/29950846
http://dx.doi.org/10.2147/NDT.S171002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016599/
https://www.ncbi.nlm.nih.gov/pubmed/29950846
http://dx.doi.org/10.2147/NDT.S171002

Ejemplares similares